Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study.

Saved in:
Bibliographic Details
Title: Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study.
Authors: Stintzing, S.1 sebastian.stintzing@med.uni-muenchen.de, Miller-Phillips, L.1, Modest, D.P.1 Dominik.modest@med.uni-muenchen.de, Fischer von Weikersthal, L.2 weikersthal.ludwig@klinikum-amberg.de, Decker, T.3 t.decker@lrz.tu-muenchen.de, Kiani, A.4 alexander.kiani@klinikum-bayreuth.de, Vehling-Kaiser, U.5 studien@vehling-kaiser.de, Al-Batran, S.-E.6 albatran.salah@khnw.de, Heintges, T.7 heintges@lukasneuss.de, Kahl, C.8 christoph.kahl@klinikum-magdeburg.de, Seipelt, G.9 onkologie-mtk@telemed.de, Kullmann, F.10 frank.kullmann@kliniken-nordoberpfalz.ag, Stauch, M.11 praxisdrstauch@t-online.de, Scheithauer, W.12 werner.scheithauer@meduniwien.ac.at, Held, S.13 s.held@clinassess.de, Moehler, M.14 moehler@mail.uni-mainz.de, Jagenburg, A.15 info@radiology-consulting.com, Kirchner, T.16 Thomas.kirchner@med.uni-muenchen.de, Jung, A.16 Andreas.jung@med.uni-muenchen.de, Heinemann, V.1 Volker.heinemann@med.uni-muenchen.de
Source: European Journal of Cancer. Jul2017, Vol. 79, p50-60. 11p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 123463997
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Stintzing%2C+S%2E%22">Stintzing, S.</searchLink><relatesTo>1</relatesTo><i> sebastian.stintzing@med.uni-muenchen.de</i><br /><searchLink fieldCode="AR" term="%22Miller-Phillips%2C+L%2E%22">Miller-Phillips, L.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Modest%2C+D%2EP%2E%22">Modest, D.P.</searchLink><relatesTo>1</relatesTo><i> Dominik.modest@med.uni-muenchen.de</i><br /><searchLink fieldCode="AR" term="%22Fischer+von+Weikersthal%2C+L%2E%22">Fischer von Weikersthal, L.</searchLink><relatesTo>2</relatesTo><i> weikersthal.ludwig@klinikum-amberg.de</i><br /><searchLink fieldCode="AR" term="%22Decker%2C+T%2E%22">Decker, T.</searchLink><relatesTo>3</relatesTo><i> t.decker@lrz.tu-muenchen.de</i><br /><searchLink fieldCode="AR" term="%22Kiani%2C+A%2E%22">Kiani, A.</searchLink><relatesTo>4</relatesTo><i> alexander.kiani@klinikum-bayreuth.de</i><br /><searchLink fieldCode="AR" term="%22Vehling-Kaiser%2C+U%2E%22">Vehling-Kaiser, U.</searchLink><relatesTo>5</relatesTo><i> studien@vehling-kaiser.de</i><br /><searchLink fieldCode="AR" term="%22Al-Batran%2C+S%2E-E%2E%22">Al-Batran, S.-E.</searchLink><relatesTo>6</relatesTo><i> albatran.salah@khnw.de</i><br /><searchLink fieldCode="AR" term="%22Heintges%2C+T%2E%22">Heintges, T.</searchLink><relatesTo>7</relatesTo><i> heintges@lukasneuss.de</i><br /><searchLink fieldCode="AR" term="%22Kahl%2C+C%2E%22">Kahl, C.</searchLink><relatesTo>8</relatesTo><i> christoph.kahl@klinikum-magdeburg.de</i><br /><searchLink fieldCode="AR" term="%22Seipelt%2C+G%2E%22">Seipelt, G.</searchLink><relatesTo>9</relatesTo><i> onkologie-mtk@telemed.de</i><br /><searchLink fieldCode="AR" term="%22Kullmann%2C+F%2E%22">Kullmann, F.</searchLink><relatesTo>10</relatesTo><i> frank.kullmann@kliniken-nordoberpfalz.ag</i><br /><searchLink fieldCode="AR" term="%22Stauch%2C+M%2E%22">Stauch, M.</searchLink><relatesTo>11</relatesTo><i> praxisdrstauch@t-online.de</i><br /><searchLink fieldCode="AR" term="%22Scheithauer%2C+W%2E%22">Scheithauer, W.</searchLink><relatesTo>12</relatesTo><i> werner.scheithauer@meduniwien.ac.at</i><br /><searchLink fieldCode="AR" term="%22Held%2C+S%2E%22">Held, S.</searchLink><relatesTo>13</relatesTo><i> s.held@clinassess.de</i><br /><searchLink fieldCode="AR" term="%22Moehler%2C+M%2E%22">Moehler, M.</searchLink><relatesTo>14</relatesTo><i> moehler@mail.uni-mainz.de</i><br /><searchLink fieldCode="AR" term="%22Jagenburg%2C+A%2E%22">Jagenburg, A.</searchLink><relatesTo>15</relatesTo><i> info@radiology-consulting.com</i><br /><searchLink fieldCode="AR" term="%22Kirchner%2C+T%2E%22">Kirchner, T.</searchLink><relatesTo>16</relatesTo><i> Thomas.kirchner@med.uni-muenchen.de</i><br /><searchLink fieldCode="AR" term="%22Jung%2C+A%2E%22">Jung, A.</searchLink><relatesTo>16</relatesTo><i> Andreas.jung@med.uni-muenchen.de</i><br /><searchLink fieldCode="AR" term="%22Heinemann%2C+V%2E%22">Heinemann, V.</searchLink><relatesTo>1</relatesTo><i> Volker.heinemann@med.uni-muenchen.de</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Cancer%22">European Journal of Cancer</searchLink>. Jul2017, Vol. 79, p50-60. 11p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=123463997
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2017.03.023
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 50
    Titles:
      – TitleFull: Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stintzing, S.
      – PersonEntity:
          Name:
            NameFull: Miller-Phillips, L.
      – PersonEntity:
          Name:
            NameFull: Modest, D.P.
      – PersonEntity:
          Name:
            NameFull: Fischer von Weikersthal, L.
      – PersonEntity:
          Name:
            NameFull: Decker, T.
      – PersonEntity:
          Name:
            NameFull: Kiani, A.
      – PersonEntity:
          Name:
            NameFull: Vehling-Kaiser, U.
      – PersonEntity:
          Name:
            NameFull: Al-Batran, S.-E.
      – PersonEntity:
          Name:
            NameFull: Heintges, T.
      – PersonEntity:
          Name:
            NameFull: Kahl, C.
      – PersonEntity:
          Name:
            NameFull: Seipelt, G.
      – PersonEntity:
          Name:
            NameFull: Kullmann, F.
      – PersonEntity:
          Name:
            NameFull: Stauch, M.
      – PersonEntity:
          Name:
            NameFull: Scheithauer, W.
      – PersonEntity:
          Name:
            NameFull: Held, S.
      – PersonEntity:
          Name:
            NameFull: Moehler, M.
      – PersonEntity:
          Name:
            NameFull: Jagenburg, A.
      – PersonEntity:
          Name:
            NameFull: Kirchner, T.
      – PersonEntity:
          Name:
            NameFull: Jung, A.
      – PersonEntity:
          Name:
            NameFull: Heinemann, V.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: Jul2017
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-print
              Value: 09598049
          Numbering:
            – Type: volume
              Value: 79
          Titles:
            – TitleFull: European Journal of Cancer
              Type: main
ResultId 1